Atorvastatin and hormone therapy influence expression of ABCA1, APOA1 and SCARB1 in mononuclear cells from hypercholesterolemic postmenopausal women

Journal of Steroid Biochemistry and Molecular Biology

Volumn 138, Issue , 2013, Pages 403-409

  Cerda, Alvaro ^a   Issa, Mustafa H ^a   Genvigir, Fabiana D V ^a   Rohde, Cintia B ^a   Cavalli, Selma A ^a   Bertolami, Marcelo C ^b   Faludi, Andre A ^b   Hirata, Mario H ^a   Hirata, Rosario D C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Hormone therapy; Hypercholesterolemia; Menopause; Reverse cholesterol transport (RCT); Statins

Indexed keywords

ABC TRANSPORTER A1; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; ATORVASTATIN; CHOLESTEROL; CREATINE KINASE; ESTRADIOL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; NORETHISTERONE ACETATE; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MONOTHERAPY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTMENOPAUSE; QUANTITATIVE ANALYSIS;

HORMONE THERAPY; HYPERCHOLESTEROLEMIA; MENOPAUSE; REVERSE CHOLESTEROL TRANSPORT (RCT); STATINS;

ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; CELLS, CULTURED; ESTRADIOL; FEMALE; HEPTANOIC ACIDS; HETEROCYCLIC COMPOUNDS; HUMANS; HYPERCHOLESTEROLEMIA; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; POSTMENOPAUSE; PYRROLES; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTOME;

EID: 84884173157     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.08.017     Document Type: Article

References (35)

1. R.P. Middelberg, T.D. Spector, R. Swaminathan, and H. Snieder Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause Arterioscler. Thromb. Vasc. Biol. 22 7 2002 1142 1147 (Pubitemid 34764865)
2. G. Benagiano, and M. Farris Why a consensus conference on hormone replacement therapy and the cardiovascular system? Maturitas 47 4 2004 245 253 (Pubitemid 38520109)
3. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000 Fertil. Steril. 75 5 2001 898 915 (Pubitemid 32401667)
4. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
5. G.F. Lewis, and D.J. Rader New insights into the regulation of HDL metabolism and reverse cholesterol transport Circ. Res. 96 12 2005 1221 1232 (Pubitemid 40962099)
6. J. Beltowski Liver X receptors (LXR) as therapeutic targets in dyslipidemia Cardiovasc. Ther. 26 4 2008 297 316
7. A. Grefhorst, M.H. Oosterveer, G. Brufau, M. Boesjes, F. Kuipers, and A.K. Groen Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol Atherosclerosis 222 2 2012 382 389
8. J. Wong, C.M. Quinn, and A.J. Brown Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux Arterioscler. Thromb. Vasc. Biol. 24 12 2004 2365 2371 (Pubitemid 39658043)
9. F.D.V. Genvigir, A.C. Rodrigues, A. Cerda, S.S. Arazi, M.A. Vieira Willrich, R. Oliveira, M.H. Hirata, E.L. Dorea, M.M. Bernik, R. Curi, and R.D.C. Hirata Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells Pharmacogenomics 11 9 2010 1235 1246
10. J.Z. Guan, N. Tamasawa, H. Murakami, J. Matsui, J. Tanabe, K. Matsuki, M. Yamashita, and T. Suda HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia J. Atheroscler. Thromb. 15 1 2008 20 25
11. M.H. Issa, A. Cerda, F.D.V. Genvigir, S.A. Cavalli, M.C. Bertolami, A.A. Faludi, M.H. Hirata, and R.D.C. Hirata Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women J. Steroid Biochem. Mol. Biol. 128 3-5 2012 139 144
12. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 4 2001 402 408 (Pubitemid 34164012)
13. P. Raggi, M. Davidson, T.Q. Callister, F.K. Welty, G.A. Bachmann, H. Hecht, and J.A. Rumberger Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT scanning (BELLES) Circulation 112 4 2005 563 571 (Pubitemid 41060797)
14. M. Ushioda, K. Makita, K. Takamatsu, F. Horiguchi, and D. Aoki Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women Horm. Metab. Res. 38 9 2006 581 586 (Pubitemid 44569142)
15. A.S. Fak, M. Erenus, H. Tezcan, O. Caymaz, P. Atagunduz, S. Oktay, and A. Oktay Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women Eur. Heart J. 21 3 2000 190 197 (Pubitemid 30137803)
16. V. Zago, V. Miksztowicz, L. Cacciagiu, F. Basilio, G. Berg, and L. Schreier High density lipoprotein is an inappropriate substrate for hepatic lipase in postmenopausal women Clin. Chim. Acta 414 2012 142 145
17. A. Cerda, M.H. Hirata, and R.D. Hirata Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport Drug Metabol. Drug Interact. 27 2 2012 101 111
18. S. Yamashita, K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, and M. Nishida Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions J. Atheroscler. Thromb. 17 5 2010 436 451
19. G. Song, J. Liu, Z. Zhao, Y. Yu, H. Tian, S. Yao, G. Li, and S. Qin Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet Lipids Health Dis. 10 2011 8
20. M. Kobayashi, K. Gouda, I. Chisaki, M. Ochiai, S. Itagaki, and K. Iseki Regulation mechanism of ABCA1 expression by statins in hepatocytes Eur. J. Pharmacol. 662 1-3 2011 9 14
21. J. Wong, C.M. Quinn, I.C. Gelissen, W. Jessup, and A.J. Brown The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation Atherosclerosis 196 1 2008 180 189
22. M. Darabi, M. Rabbani, M. Ani, E. Zarean, M. Panjehpour, and A. Movahedian Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy Gynecol. Endocrinol. 27 9 2011 701 705
23. K.J. Rayner, Y. Suarez, A. Davalos, S. Parathath, M.L. Fitzgerald, N. Tamehiro, E.A. Fisher, K.J. Moore, and C. Fernandez-Hernando MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 5985 2010 1570 1573
24. T. Maejima, H. Yamazaki, T. Aoki, T. Tamaki, F. Sato, M. Kitahara, and Y. Saito Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell Biochem. Biophys. Res. Commun. 324 2 2004 835 839 (Pubitemid 39345591)
25. S. Qin, T. Koga, S.H. Ganji, V.S. Kamanna, and M.L. Kashyap Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells Metabolism 57 7 2008 973 979 (Pubitemid 351814690)
26. G. Martin, H. Duez, C. Blanquart, V. Berezowski, P. Poulain, J.C. Fruchart, J. Najib-Fruchart, C. Glineur, and B. Staels Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I J. Clin. Invest. 107 11 2001 1423 1432 (Pubitemid 32522036)
27. B. Zhang, K. Saku, and T. Ohta In vivo metabolism of HDL, apo A-I, and lp A-I, and function of HDL - a clinical perspective J. Atheroscler. Thromb. 7 2 2000 59 66
28. A. Cerda, F.D. Genvigir, A.C. Rodrigues, M.A. Willrich, E.L. Dorea, M.M. Bernik, S.S. Arazi, R.D. Oliveira, M.H. Hirata, and R.D. Hirata Influence of Polymorphisms and Cholesterol-Lowering Treatment on SCARB1 mRNA Expression J. Atheroscler. Thromb. 2011
29. D. Lopez, and M.P. McLean Estrogen regulation of the scavenger receptor class B gene: anti-atherogenic or steroidogenic, is there a priority? Mol. Cell. Endocrinol. 247 1-2 2006 22 33 (Pubitemid 43277704)
30. X. Zhang, A.N. Moor, K.A. Merkler, Q. Liu, and M.P. McLean Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors Endocrinology 148 11 2007 5295 5304 (Pubitemid 350012650)
31. O. Chiba-Falek, M. Nichols, S. Suchindran, J. Guyton, G.S. Ginsburg, E. Barrett-Connor, and J.J. McCarthy Impact of gene variants on sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study BMC Med. Genet. 11 2010 9
32. S.H. Najafi-Shoushtari, F. Kristo, Y. Li, T. Shioda, D.E. Cohen, R.E. Gerszten, and A.M. Näär MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis Science 328 5985 2010 1566 1569
33. E.J. Tarling, and P.A. Edwards Dancing with the sterols: critical roles for ABCG1, ABCA1, miRNAs, and nuclear and cell surface receptors in controlling cellular sterol homeostasis Biochim. Biophys. Acta 1821 3 2012 386 395
34. Y.W. Hu, Q. Wang, X. Ma, X.X. Li, X.H. Liu, J. Xiao, D.F. Liao, J. Xiang, and C.K. Tang TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells J. Atheroscler. Thromb. 17 5 2010 493 502
35. A.V. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Phillips, M.L. Mucksavage, R.L. Wilensky, E.R. Mohler, G.H. Rothblat, and D.J. Rader Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2 2011 127 135